Clinical Trials Logo

Clinical Trial Summary

Anal fistula is a very common disease with a high impact on life quality. The only commonly accepted treatment option is surgery. A wide range of operations and techniques have been developed all suffering from a relatively high recurrence rate.

The investigators propose the combination of the mucosal advancement flap with application of platelet-rich plasma (PRP) in the fistulectomy site. This study aims to test the hypothesis that by applying PRP the healing rate of complicated anal fistulas can be improved in comparison to a control group where the operation is performed without addition of PRP.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02678936
Study type Interventional
Source University Hospital, Basel, Switzerland
Contact
Status Withdrawn
Phase Phase 4
Start date November 2015

See also
  Status Clinical Trial Phase
Terminated NCT02423330 - A Prospective Evaluation of the Strattice-LIFT to Treat Anal Fistula Early Phase 1
Recruiting NCT01997645 - Surgical Treatment of High Perianal Fistulas N/A
Completed NCT04844593 - A Study Using Artificial Intelligence to Identify Adults With Complex Perianal Fistulas Associated With Crohn's Disease
Recruiting NCT01615302 - Is the Use of Blood Platelets Effective in the Treatment of Difficult Fistulas Related to the Anal Sphincter? N/A
Recruiting NCT05390151 - Laser Assisted Treatment of Fistula In Ano N/A
Completed NCT02402543 - Pre-Emptive Analgesia in Ano-Rectal Surgery N/A
Completed NCT04876690 - A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas
Completed NCT03864718 - Photodynamic Therapy in Anal Fistula
Active, not recruiting NCT00517296 - Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas N/A
Withdrawn NCT05407766 - Mesenchymal Stem Cells (MSCs) for Perianal Fistula Phase 1